These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 36880288)

  • 1. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
    Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
    CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A.
    Liu Y; Wang L; Xie F; Wang X; Hou Y; Wang X; Liu J
    Curr Neurovasc Res; 2020; 17(3):241-248. PubMed ID: 32286945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
    PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Zhang ZX; Zhao RP; Wang DS; Wang AN
    Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.
    Jiang Y; Zhang Y; Su L
    Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease.
    Park H; Lee YB; Chang KA
    Int J Biol Sci; 2022; 18(5):2220-2234. PubMed ID: 35342350
    [No Abstract]   [Full Text] [Related]  

  • 7. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
    Li J; Chen W; Yi Y; Tong Q
    J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
    Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
    Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer's disease.
    Zhu Y; Wang J
    Neurol Sci; 2015 Jul; 36(7):1181-8. PubMed ID: 25596147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease.
    Pan K; Chen S; Wang Y; Yao W; Gao X
    Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.
    Lanzillotta A; Sarnico I; Benarese M; Branca C; Baiguera C; Hutter-Paier B; Windisch M; Spano P; Imbimbo BP; Pizzi M
    J Mol Neurosci; 2011 Sep; 45(1):22-31. PubMed ID: 21181298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
    Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
    Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-326 decreases tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in Alzheimer's disease.
    He B; Chen W; Zeng J; Tong W; Zheng P
    J Cell Physiol; 2020 Jan; 235(1):480-493. PubMed ID: 31385301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's Disease.
    Wang L; Shui X; Mei Y; Xia Y; Lan G; Hu L; Zhang M; Gan CL; Li R; Tian Y; Wang Q; Gu X; Chen D; Zhang T; Lee TH
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology.
    Sierksma A; Lu A; Salta E; Vanden Eynden E; Callaerts-Vegh Z; D'Hooge R; Blum D; Buée L; Fiers M; De Strooper B
    Mol Neurodegener; 2018 Oct; 13(1):54. PubMed ID: 30314521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
    Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
    Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease.
    He Z; Zhang H; Li X; Tu S; Wang Z; Han S; Du X; Shen L; Li N; Liu Q
    Phytomedicine; 2023 Jan; 109():154555. PubMed ID: 36610160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.
    Yan Y; Yan H; Teng Y; Wang Q; Yang P; Zhang L; Cheng H; Fu S
    J Gene Med; 2020 Dec; 22(12):e3268. PubMed ID: 32891070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
    Liu W; Zhao J; Lu G
    Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.